Elbonix 50 MG (Eltrombopag)

نشر بتاريخ 2025-08-14 07:03:52

333

Elbonix (Eltrombopag) 50 mg treats low platelet counts in adults with chronic immune thrombocytopenia (ITP) unresponsive to other therapies, helping reduce bruising and bleeding risks. Approved in 2012, it’s also used in chronic hepatitis C patients to maintain platelet levels during interferon-based treatment.

الرجاء تسجيل الدخول , للأعجاب والمشاركة والتعليق على هذا!

إعلان مُمول

Technology

Global 3D Display Market Set to Reach USD 494.9 Billion by 2031 Amid Growing Demand in Gaming, AR/VR Integration, and Medical Visualization

The global 3D display market, valued at USD 101.8 billion in 2022, is projected to grow at a...

بواسطة 2025-06-25 20:22:28 0 964

News

Rafale Fighter ‘Shoots Down’ Stratospheric Balloons Using MICA Missiles In French Test; Mirage-2000 Joins In

France has shot down “stratospheric balloons operating at very high altitude,” using...

بواسطة 2025-06-28 08:42:13 0 629

Networking

Smart Card IC Market Set to Reach $5.2 Billion by 2034: Key Trends and Insights

Smart cards, also known as integrated circuit cards (ICCs), are portable plastic cards embedded...

بواسطة 2025-01-08 19:20:08 0 2كيلو بايت

أخرى

Choose the Right Type of Working Capital Loan

When it comes to managing daily operations, every business needs enough cash flow. That’s...

بواسطة 2025-08-08 06:12:57 0 594

Health

How Advanced Eye Care is Transforming Corneal Ulcer Treatment

Introduction The human eye is a delicate organ, and when something as serious as a corneal ulcer...

بواسطة 2025-01-10 10:25:23 0 2كيلو بايت